Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023418 (
leukemia
)
93,477
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study is to investigate the synergistic effect of Anglica polysaccharide sulfate (APS-1) and
Combivir
, an anti-AIDS drug, on murine
leukemia
virus in vivo. As the results shown, the virus replication was significantly decreased by the combination of APS-1 and
Combivir
, which tended to be further decreased (58% inhibition) when compared with that of
Combivir
alone (51% inhibition). Furthermore, both the percentage of CD4(+) cells and CD4(+)/CD8(+) ratio in peripheral blood cells were significantly enhanced by this combined administration, while the CD4(+) cells was only slightly increased and CD4(+)/CD8(+) ratio was not affected by
Combivir
alone. Additionally, combination of APS-1 and
Combivir
also alleviated the toxicity of
Combivir
. APS-1 not only increased the survival rate of mice administered with LD(50) dose of
Combivir
, but also reduced the hematologic toxicity induced by
Combivir
, RBC, HGB and PLT were restored to normal level. These results suggest that APS-1 had synergistic effect with
Combivir
, which provided new insight into the potential clinical use of polysaccharide sulfate in anti-AIDS field.
...
PMID:Synergistic antivirus effect of combined administration of Combivir with Angelica polysaccharide sulfate. 2315 62
Tropical spastic paraparesis (TSP) or human T-cell
leukemia
virus-type 1 (HTLV-I)-associated myelopathy is caused by human T-lymphotropic virus type 1. It is a slow, progressive spastic paraparesis with significant morbidity and causing profound repercussions on quality of life. No therapies have been found to persistently improve the outcome in these patients. We present a patient with HTLV-1-associated myelopathy/TSP (HAM/TSP) who was treated with
Combivir
(lamivudine-zidovudine, GlaxoSmithKline, London, UK). She was walker-dependent for several years but, soon after treatment with lamivudine-zidovudine, was able to walk using only a cane. The role of lamivudine-zidovudine should be investigated further in this patient population.
...
PMID:Tropical spastic paraparesis treated with Combivir (lamivudine-zidovudine). 2347 75